Reopening America

New Study Shows Omicron Variant More Resistant to Vaccines, but Appears to Cause Less Severe Illness

We are getting more information on the Omicron variant from the first large real-world study in South Africa and see protection from hospitalization fall to 70% and against infection fall to 33%. This study pitted the new variant against two shots of Pfizer, which has been widely used in the area. Denise Roland, healthcare reporter at the WSJ, joins us for what we are seeing from Omicron, more transmissible and so far, milder infections. Learn more about your ad-choices at <a href="https://www.iheartpodcastnetwork.com">https://www.iheartpodcastnetwork.com</a>See <a href="https://omnystudio.com/listener">omnystudio.com/listener</a> for privacy information.

We have shifted into a new phase in the coronavirus pandemic. We are social distancing, washing our hands, wearing face masks, and we are Reopening America. Oscar Ramirez from the Daily Dive Podcast updates you on any new information about the virus and vaccine development, but will focus on how cities, states, and industries affected by the shutdown are opening back up.